1-4 of 4
Greg Rossi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Randomized, Double-Blind, Placebo-Controlled Study of Darbepoetin alfa Every 3 Weeks for the Treatment of Chemotherapy-Induced Anemia.

Kerry Taylor, MD, Peter Ganly, MD, Veena Charu, MD, Joseph DiBenedetto, MD, Karolyn Kracht, PhD, Greg Rossi, PhD, Enrique Hernandez, MD
Journal: Blood
Blood (2005) 106 (11): 3556.
https://doi.org/10.1182/blood.V106.11.3556.3556
Published: 2005
Journal Articles

Effectiveness of Darbepoetin alfa Administered Every 3 Weeks on Clinical Outcomes in Patients with Hematologic Malignancies and Chemotherapy-Induced Anemia.

Ralph Vincent Boccia, Peter T. Silberstein, Simon Tchekmedyian, Dianne Tomita, Greg Rossi, Greg Otterson
Journal: Blood
Blood (2005) 106 (11): 3767.
https://doi.org/10.1182/blood.V106.11.3767.3767
Published: 2005
Journal Articles

An Evaluation of the Effectiveness of Darbepoetin alfa 300 mcg Every 3 Weeks (Q3W) on Clinical Outcomesin Cancer Patients with Chemotherapy-Induced Anemia.

Ralph Vincent Boccia, Delong Liu, Peter Silberstein, Simon Tchekmedyian, Dianne Tomita, Greg Rossi, Greg Otterson
Journal: Blood
Blood (2004) 104 (11): 5310.
https://doi.org/10.1182/blood.V104.11.5310.5310
Published: 2004
Journal Articles

Efficacy of Darbepoetin Alfa in the Treatment of Chemotherapy-Induced Anemia in Non-Hodgkin’s Lymphoma.

Stephanie A. Gregory, MD, Douglas W. Blayney, MD, Saroj Vadhan-Raj, MD, Dianne K. Tomita, MPH, Greg Rossi, PhD, Barry Mirtsching, MD
Journal: Blood
Blood (2004) 104 (11): 3296.
https://doi.org/10.1182/blood.V104.11.3296.3296
Published: 2004